Product review of Springer AdisInsight (value - help & training; competitors; development; pricing)
16th June 2020

In the final part of our product review of AdisInsight from Springer Nature, a database of international drug research offering a single access location for current evidence on drug developments and treatments, we find out what help and training is available to users as well as competition in this area, including Cortellis from Clarivate Analytics, Trialtrove from Pharma Intelligence and Orbit Intellixir from Questel. We also find out about its plans to improve end-user privacy and introduce content visualisation.

Note: Full review in Subscription Report (PDF)

Read

Product review of Springer AdisInsight (technology - search & user interface; outputs & alerts; administration)
15th June 2020

In the third part of our product review of AdisInsight from Springer Nature, a database of international drug research offering a single access location for current evidence on drug developments and treatments, we explore the technology behind the product. We focus on the options available to search, share and export its five content sets and how administrators can better monitor usage.

Note: Full review in Subscription Report (PDF)

Read

Product review of Springer AdisInsight (sources - content and coverage)
12th June 2020

In the second part of our product review of AdisInsight from Springer Nature, a database of international drug research offering a single access location for current evidence on drug developments and treatments, we look at its content. In particular, its five content sets; drugs, clinical trials, deals, safety reports and patents. We also find out about its extensive editorial process.

Note: Full review in Subscription Report (PDF)

Read

Product review of Springer AdisInsight (key advantages; introduction; contact details)
11th June 2020

AdisInsight from Springer Nature is a comprehensive scientific database of international drug research, offering a single access location for current evidence on drug developments and treatments. In the first part of Jinfo's updated product review, we take a look at the company behind the product, its key advantages, what's changed since our last review in 2017, and the product's value to those organisations working within the healthcare sector.

Note: Full review in Subscription Report (PDF)

Read

Product review of Springer AdisInsight
11th June 2020

Read

Webinar deck - risk assessment on information licensing
10th June 2020

Read

Defining success through the value chain
10th June 2020

To demonstrate the value of your information strategy, you need to be specific about your goals. This article looks at how you can do this using Jinfo's value chain and covers the examples of efficiency, innovation, risk management and transparency, amongst others.

Note: This article is part of the Focus on Value Chain.

Read

Risk assessment on information licensing - focus on use-cases
10th May 2020

Read

Jinfo survey - challenges facing information teams
8th June 2020

Read

Jinfo survey - challenges facing information teams (part 5 - how can information professionals and suppliers have better partnerships?)
5th June 2020

The final part of our five-part report looking at the findings of Jinfo's market research survey on behalf of Springer Nature designed to elicit the opinions of corporate information centres on open access materials, products and services, focuses on respondents' perceived value of publisher-produced resources in this area and how dialogue could be enhanced between them.

Read